ArticleNPJ breast cancer2023

Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer.

Mohammadhadi Khorrami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.